FL Miami의 유방암 임상 시험
유방암 관련 연구 42개가 Miami 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
피험자 모집 중1/2상
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
피험자 모집 중3상
- Dwoskin Proton Therapy Center, Miami
- Miami Cancer Institute, Miami
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
피험자 모집 중3상
- Miami Cancer Institute, Miami
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
피험자 모집 중3상
- Research Site, Miami
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
피험자 모집 중2상
- Sylvester Comprehensive Cancer Center, Miami
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
피험자 모집 중1/2상
- University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
피험자 모집 중
- Werheim Cancer Institute, Miami
Precise Oncology Interventions in Nutrition and Training (OnPoint)
피험자 모집 중건강한 지원자 환영
- University of Miami, Miami
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
피험자 모집 중3상
- University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
피험자 모집 중건강한 지원자 환영
- TopLine MD Alliance, Miami
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
피험자 모집 중2상
- Baptist Alliance Miami Cancer Institute, Miami
A Study of Breast Cancer Risk Factors and Outcomes of People in Florida
피험자 모집 중관찰 연구건강한 지원자 환영
- University of Miami (Data Collection Only), Miami
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
피험자 모집 중3상
- Miami Cancer Institute at Baptist Health Inc., Miami
- University of Miami, Miami
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
피험자 모집 중1상
- University of Miami, Miami
A Phase 1/1b Study of IAM1363 in HER2 Cancers
피험자 모집 중1상
- University of Miami, Miami
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
피험자 모집 중2상
- BAPTIST ALLIANCE - MCI (Data Collection Only), Miami
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
피험자 모집 중1/2상
- Sylvester Comprehensive Cancer Center, Miami
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
피험자 모집 중3상
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- Miami Cancer Institute, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
피험자 모집 중3상
- University Of Miami-SCCC-Miami, Miami
- University of Miami_SCCC - Kendall, Miami
ATEMPT 2.0: Adjuvant T-DM1 vs TH
피험자 모집 중2상
- Miami Cancer Institute/Baptist Hospital of Miami, Miami
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
피험자 모집 중3상
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- Miami Cancer Institute, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC
피험자 모집 중2상
- Baptist Health Herbert Wertheim Cancer Institute, Miami
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
피험자 모집 중3상
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
피험자 모집 중2상
- Miami Baptist Cancer Institute/, Miami
SABER Study for Selected Early Stage Breast Cancer
피험자 모집 중
- University of Miami, Miami
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
피험자 모집 중2상
- University of Miami Hospital and Clinics, Miami
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
피험자 모집 중3상
- Miami Cancer Institute, Miami
Phase III Trial of Brain MRI Surveillance in Stage IV Breast Cancer
피험자 모집 중3상
- Baptist Health South Florida, Miami
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
피험자 모집 중관찰 연구건강한 지원자 환영
- University of Miami, Miami
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
피험자 모집 중1/2상
- Sylvester Comprehensive Cancer Center - University of Miami Health System, Miami
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
피험자 모집 중2상
- Miami Cancer Institute at Baptist Health (Kendall), Miami
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
피험자 모집 중3상
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
피험자 모집 중1/2상
- Miami Cancer Institute at Baptist Health, Miami
Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences
피험자 모집 중
- University of Miami, Miami
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
피험자 모집 중2상
- Baptist Alliance - McI, Miami
With Love, Grandma ("Con Cariño, Abuelita") Pilot Study
피험자 모집 중
- University of Miami, Miami
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
피험자 모집 중1상
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
피험자 모집 중관찰 연구건강한 지원자 환영
- Miami Cancer Institute, Miami
Breast Re-irradiation After Second Ipsilateral Lumpectomy
피험자 모집 중
- Miami Cancer Institute at Baptist Health, Inc., Miami
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
피험자 모집 중관찰 연구
- Massive Bio SYNERGY-AI site, Miami
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
피험자 모집 중관찰 연구
- Sylvester Comprehensive Cancer Center - University of Miami, Miami
- Miami Cancer Institute at Baptist Health, Inc, Miami
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
피험자 모집 중2상
- AP Medical Research, Miami
다른 도시의 유방암 시험
- New York City, NY연구 134개
- Houston, TX연구 126개
- Boston, MA연구 111개
- Nashville, TN연구 80개
- Los Angeles, CA연구 72개
- Edison, NJ연구 68개
- St. Louis, MO연구 64개
- Durham, NC연구 63개
- Queens, NY연구 63개
- Chicago, IL연구 58개
- Philadelphia, PA연구 56개
- Dallas, TX연구 55개
Miami의 다른 연구
- 암 (전체)연구 36개
- 비소세포폐암연구 31개
- 전립선암연구 27개
- 비만연구 27개
- 급성 골수성 백혈병연구 24개
- 전이성 암연구 24개
- 난소암연구 23개
- 과체중연구 23개
- 다발성 골수종연구 21개
- 궤양성 대장염연구 21개
- 알츠하이머병연구 20개
- 폐암연구 20개
ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.